Sanofi (ADR)
Develops immunology-focused medicines and vaccines across a broad international footprint.
$44.83
After-hours close+0.01 (+0.02%)
At close$44.82(−0.04%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $1.71 | — | — |
| Jul 2026 | $1.10 | $1.21 | +10.0% |
| Apr 2026 | $1.06 | $1.10 | +3.8% |
| Jan 2026 | $0.84 | $0.89 | +6.0% |
| Oct 2025 | $1.60 | $1.70 | +6.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 23, 2026 | $1.71 | — | — | $15.18B | — | — |
| Jul 30, 2026 | $1.10 | $1.21 | +10.0% | $13.02B | $14.06B | +8.0% |
| Apr 23, 2026 | $1.06 | $1.10 | +3.8% | $12.68B | $12.94B | +2.1% |
| Jan 29, 2026 | $0.84 | $0.89 | +6.0% | $11.71B | $14.34B | +22.4% |
| Oct 24, 2025 | $1.60 | $1.70 | +6.2% | $11.11B | $15.43B | +38.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 31, 2025 | ||||||
| Apr 24, 2025 | ||||||
| Jan 30, 2025 | ||||||
| Oct 25, 2024 | ||||||
| Jul 25, 2024 | ||||||
| Apr 25, 2024 | ||||||
| Feb 1, 2024 | ||||||
| Oct 27, 2023 | ||||||
| Jul 28, 2023 | ||||||
| Apr 27, 2023 | ||||||
| Feb 3, 2023 | ||||||
| Oct 28, 2022 | ||||||
| Jul 28, 2022 | ||||||
| Apr 28, 2022 | ||||||
| Feb 4, 2022 | ||||||
| Oct 28, 2021 | ||||||
| Jul 29, 2021 | ||||||
| Apr 28, 2021 | ||||||
| Feb 5, 2021 | ||||||
| Oct 29, 2020 | ||||||
| Jul 29, 2020 | ||||||
| Apr 24, 2020 | ||||||
| Feb 6, 2020 | ||||||
| Oct 31, 2019 | ||||||
| Jul 29, 2019 | ||||||
| Apr 26, 2019 | ||||||
| Feb 7, 2019 | ||||||
| Oct 31, 2018 | ||||||
| Jul 31, 2018 | ||||||
| Apr 27, 2018 | ||||||
| Feb 7, 2018 | ||||||
| Nov 2, 2017 | ||||||
| Jul 31, 2017 | ||||||
| Apr 28, 2017 | ||||||
| Feb 8, 2017 | ||||||
| Oct 28, 2016 | ||||||
| Jul 29, 2016 | ||||||
| Apr 29, 2016 | ||||||
| Feb 9, 2016 | ||||||
| Oct 29, 2015 | ||||||
| Jul 30, 2015 | ||||||
